In the life science portfolio, NOF has been expanding its share of the biocompatible materials market in earnest, having consolidated its operational system after the company's success in the development of the production technology for LIPIDURE^®, MPC polymers (2-methacryloyloxyethyl-phosphorylcholine) with phospholipid polar groups.

The application extends across eye care, skin care, oral care, and other care products, as well as medical devices, and diagnostic pharmaceuticals. Our products are highly appreciated in each of these fields.

Our wealth of technologies in molecular designing, refining, and evaluation has been fully mobilized for further development of new applications and products. Armed with our key technologies, we will strive to create innovative values and thereby enhance quality of life (QOL).